Fox et al. (2007) demonstrated that administering tranylcypromine and 5-HTP (or clorgyline and 5-HTP) was necessary for SS symptoms to appear in mice with normal SERT functioning. This evidence concerns the gene SLC6A4 and synovial sarcoma.